We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
CJC 1295 is the third in that category of type 1 growth hormone secreting peptides but it may again may we don't know have some safety issues that still need to be resolved making suelin and testelin at least to my mind better options should you decide to go down this path
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
to my mind given that there are decent Alternatives in serel and or tesamorelin I don't know why anyone would specifically select cjc-1295 until all these safety issues have been resolved